Their forecasts range from $3.25 to $3.75. 1y Target Est 3.91 Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. The stock's lowest day price was 1.47. Lipper shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Target Price: Price: 2.01 Price Target: Upgrade: Price Target Upside (Daily) Upgrade Based on 2 analysts offering 12 month price targets for CloudMD Software & Services in the last 3 months. Premium. Greenbrook TMS price target raised to C$5.50 from C$3.50 at Clarus 11/12/20 Stifel Greenbrook TMS price target raised to C$3.10 from C$3 at Stifel 05/22/20 Canaccord Greenbrook TMS price target lowered to C$3.25 from C$3.50 at Canaccord 02/24/20 Canaccord Greenbrook TMS … Analyst Price Target on DOCRF. It has also generated negative returns for investors over the last 30 days. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Fundamental company data and analyst estimates provided by FactSet. Any copying, republication or redistribution of Lipper content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper. Volatility Over Time : DOC's weekly volatility (10%) has been stable over the past year. Find real-time DOCRF - CloudMD Software & Services Inc stock quotes, company profile, news and forecasts from CNN Business. Fundamental company data provided by Zacks Investment Research. Source: FactSet. 1y Target Est 9.00 Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. The stock price for . Sources: FactSet, Tullett Prebon, Commodities & Futures: Futures prices are delayed at least 10 minutes as per exchange requirements. Latest ... 7:36a Expedia stock price target raised to $135 from $115 at Mizuho Learn more. Want to see which stocks are moving? Follow Crypto, Mining, Cannabis, and Energy stocks and get free research reports here. Learn more. Based on our forecasts, a long-term increase is expected, the "DOCRF" stock price prognosis for 2026-02-25 is 13.244 USD. Sources: FactSet, Tullett Prebon, Currencies: Currency quotes are updated in real-time. Cryptocurrencies: Cryptocurrency quotes are updated in real-time. Start Your Risk-Free Trial Subscription Here, Russia to make Sputnik V vaccine in Italy; a 1st in EU, Anheuser-Busch Inbev Stock is a Must Own Re-Opening Play, Technology rebound leads stocks higher on Wall Street, GE, AerCap join air leasing businesses in $30 billion deal, ChargePoint Stock is a Speculative EV Play Only for the Nimble and Risk-Tolerant, US officials: report on oil and gas sale ban due by summer, FlexShopper Stock: Small Price, Big Upside, Casey's General Stores is Still a Good Buy, Why Visa (NYSE:V) Stock Deserves More Credit, Thor Industries (NYSE:THO) Deserves A Spot In Your Pantheon Of Stocks, Texas Roadhouse Looks Like a Post-Pandemic Winner, Purple Innovation Attempts Rebound After Earnings Dive, Great Time to Buy Goodyear Tires (NYSE: GT) Stock Here, 7 Internet of Things Stocks That Are a Perfect Fit to Our Connected Future, 7 Undervalued Stocks That Deserve More Attention, 7 Semiconductor Stocks Set to Gain From the Chip Shortage, 7 Great Dividend Stocks to Buy For a Comfortable Retirement, 7 Penny Stocks That Don’t Care About Robinhood, 7 Hotel Stocks Just Waiting For the Vaccine, 7 Stocks to Watch When Student Debt Forgiveness Gets Passed, 7 Healthcare Stocks Delivering Innovation in 2021, 7 Lithium Stocks That Will Power the Electric Vehicle Boom, 7 Electric Vehicle (EV) Stocks That Have Real Juice, Receive Analysts' Upgrades and Downgrades Daily. The high price target for DOCRF is $3.75 and the low price target for DOCRF is $3.25. Latest Share Price and Events Stable Share Price : DOC is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 10% a week. 1y Target Est N/A Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Echelon Wealth Partners analyst Rob Goff maintained a Buy rating on CloudMD Software & Services (DOCRF – Research Report) on January 19 and set a price target of C$3.25.The company’s shares closed last Tuesday at $2.12. Sources: FactSet, Dow Jones, Bonds: Bond quotes are updated in real-time. Headline. During the day the stock fluctuated 7.14% from a day low at $1.68 to a day high of $1.80. Source: FactSet, Markets Diary: Data on U.S. Overview page represent trading in all U.S. markets and updates until 8 p.m. See Closing Diaries table for 4 p.m. closing data. Top Stocks by Target Price Dividend Discount Model Stock Valuation Industry Rank Best ETFs "A" Rated ETFs Best ETF Categories High Yield ETFs ... (DOCRF): … The average price target is $2.77 with a high forecast of $2.97 and a low forecast of $2.57. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 View DOCRF historial stock data and compare to other stocks and exchanges. The CloudMD Software & Services Inc. stock price gained 2.42% on the last trading day (Monday, 8th Mar 2021), rising from $1.65 to $1.69. CloudMD Software & Services (DOCRF) In a report released yesterday, Doug Taylor from Canaccord Genuity maintained a Buy rating on CloudMD Software & Services, with a price target of C$3.50. © American Consumer News, LLC dba MarketBeat® 2010-2021. Get daily stock ideas top-performing Wall Street analysts. Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. Our Price Target. To see all exchange delays and terms of use please see disclaimer. View which stocks are hot on social media with MarketBeat's trending stocks report. FactSet (a) does not make any express or implied warranties of any kind regarding the data, including, without limitation, any warranty of merchantability or fitness for a particular purpose or use; and (b) shall not be liable for any errors, incompleteness, interruption or delay, action taken in reliance on any data, or for any damages resulting therefrom. The company’s shares closed last Tuesday at $1.79. 2 Wall Street analysts have set twelve-month price targets for CloudMD Software & Services in the last year. In a report issued on January 12, Rob Goff from Echelon Wealth Partners assigned a Buy rating to CloudMD Software & Services (DOCRF – Research Report), with a price target of C$3.25. The dark blue line represents the company's actual price. Their average twelve-month price target is $3.50, predicting that the stock has a possible upside of 112.12%. Cloudmd Software has a very high chance of experiencing financial distress in the next few years of operation. Being an early mover in the largely untapped telehealth sector, CloudMD should be able to capture a significant share of the market via its cash position and inorganic growth strategy. Find real-time DOCRF - CloudMD Software & Services Inc stock quotes, company profile, news and forecasts from CNN Business. As of 2021 March 04, Thursday current price of DOCRF stock is 1.960$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception). The company’s shares closed last Thursday at $2.00. DOCRF updated stock price target summary. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy." MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. The chart below shows how a company's share price and consensus price target have changed over time. 2 Wall Street analysts have issued ratings and price targets for CloudMD Software & Services in the last 12 months. VANCOUVER, British Columbia, Feb. 22, 2021 -- CloudMD Software & Services Inc. (DOCRF), a healthcare technology company revolutionizing the delivery of care, is pleased to announce that it has signed a definitive agreement to acquire IDYA4, a leading health technology company focused on data interoperability and cybersecurity based in the United States. Go to the homepage. Goff has an average return of 89.0% when recommending CloudMD Software & Services. View All DOCRF News News. Copyright © FactSet Research Systems Inc. All rights reserved. Taylor has an average return of 81.6% when recommending CloudMD Software & Services. The firm presently has a “buy” rating on the stock. Source: Kantar Media, DOCRF will report FY 2021 earnings on 03/02/2022, DOCRF will report Q4 earnings on 06/03/2021, News Corp is a network of leading companies in the worlds of diversified media, news, education, and information services. Sources: CoinDesk (Bitcoin), Kraken (all other cryptocurrencies), Calendars and Economy: 'Actual' numbers are added to the table after economic reports are released. Learn everything you need to know about successful options trading with this three-part video course. Change value during the period between open outcry settle and the commencement of the next day's trading is calculated as the difference between the last trade and the prior day's settle. Get short term trading ideas from the MarketBeat Idea Engine. Canaccord Genuity analyst Doug Taylor raised the price target on CloudMD Software & Services Inc (DOC:CN) (OTC: DOCRF) to Cdn$3.75 (from Cdn$3.25) while maintaining a Spec. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Company partners with Medical Confidence, a CloudMD company, to provide plan members on disability with timely access to care and treatmentTORONTO, March 2, 2021 /CNW/ - Medavie Blue Cross has partnered with Medical Confidence (part of CloudMD (TSXV: DOC)) to … The company’s shares closed last Tuesday at $1.84. CloudMD Software & Services Inc has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. Your current $100 investment may be up to $675.71 in 2026. You can opt out at any time. Dow Jones, a News Corp company About WSJ. Do Not Sell My Information. … During the day the stock fluctuated 7.14% from a day low at $1.68 to a day high of $1.80. We use cookies and browser capability checks to help us deliver our online services, including to learn if you enabled Flash for video or ad blocking. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Sources: FactSet, Dow Jones, ETF Movers: Includes ETFs & ETNs with volume of at least 50,000. Data are provided 'as is' for informational purposes only and are not intended for trading purposes. Canaccord Genuity has the highest price target set, predicting DOCRF will reach $3.75 in … 2 brokerages have issued 12-month target prices for CloudMD Software & Services' shares. There are currently 2 buy ratings for the stock, resulting in a consensus rating of "Buy.". CloudMD was one of the sponsors for the Benzinga Global Small Cap Conference that took place on December 8-9, 2020. Mutual Funds & ETFs: All of the mutual fund and ETF information contained in this display, with the exception of the current price and price history, was supplied by Lipper, A Refinitiv Company, subject to the following: Copyright © Refinitiv. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. As of 2021 March 04, Thursday current price of DOCRF stock is 1.960$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. CloudMD Software & Services Inc has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. In a report issued on December 17, Rob Goff from Echelon Wealth Partners assigned a Buy rating to CloudMD Software & Services (DOCRF – Research Report), with a price target of C$3.25. Reply Like (4) gopher2. Next. Greenbrook TMS price target raised to C$5.50 from C$3.50 at Clarus 11/12/20 Stifel Greenbrook TMS price target raised to C$3.10 from C$3 at Stifel 05/22/20 Canaccord Greenbrook TMS price target lowered to C$3.25 from C$3.50 at Canaccord 02/24/20 Canaccord Greenbrook TMS … View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Get early insights on hidden secret gems on MicroSmallCap. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Wire. With a 5-year investment, the revenue is expected to be around +575.71%. June 24, 2020 admin Trading Ideas Comments Off on Morgan Stanley raises Disney price target, as it’s ‘uniquely positioned’ to move ESPN fully into streaming On Wednesday, Morgan Stanley analyst Benjamin Swinburne raised his price target on shares of Disney, from $125 to $135, as he finds the company to be ‘uniquely positioned’ to bring its ESPN family directly to consumers. CloudMD (OTC: DOCRF) to Drive North American Clinic Expansion with Seasoned Leadership. CloudMD Software (OTC: DOCRF) is $1.939 last updated Today at 5:27:40 PM. Sources: FactSet, Dow Jones, Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings. CloudMD Software & Services (OTCMKTS:DOCRF) Price Target Raised to $3.75 Posted by Eileen French on Feb 17th, 2021 CloudMD Software & Services (OTCMKTS:DOCRF) had its price objective raised by investment analysts at Canaccord Genuity from $3.25 to $3.75 in a research note issued on Wednesday, The Fly reports. MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. January 29, 2021 admin Newsmakers Comments Off on CloudMD ... Tesla stock gets second $1,000+ price target, from Argus Research. Change value during other periods is calculated as the difference between the last trade and the most recent settle. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. About the CloudMD Software & Services Inc stock forecast. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. The stock price for . Being an early mover in the largely untapped telehealth sector, CloudMD should be able to capture a significant share of the market via its cash position and inorganic growth strategy. The lighter blue line represents the stock's consensus price target. Their average twelve-month price target is $3.50, predicting that the stock has a possible upside of 90.53%. The company’s shares closed last Thursday at $2.00. The high price target for DOCRF is $3.75 and the low price target for DOCRF is $3.25. According to TipRanks.com, Goff is ranked #40 out of 7257 analysts. Telemedicine company CloudMD Software & Services (OTCPK:DOCRF) has entered into an agreement with Canaccord Genuity, Beacon Securities and Echelon Wealth Partners for a … CloudMD Software & Services (OTCMKTS:DOCRF) had its price objective raised by investment analysts at Canaccord Genuity from $3.25 to $3.75 in a research note issued on Wednesday, The Fly reports. What price target have analysts set for DOCRF? Go to the homepage. Receive a free world-class investing education from MarketBeat. … 30 Nov. 2020, 2:27 PM. The price has fallen in 7 of the last 10 days and is down by -22.28% for this period. Identify stocks that meet your criteria using seven unique stock screeners. The price has fallen in 7 of the last 10 days and is down by -22.28% for this period. All rights reserved. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Telemedicine has gotten a lot of attention as a result of COVID-19. View today's stock price, news and analysis for CloudMD Software & Services Inc. (DOCRF). Canaccord Genuity’s price target would suggest a potential upside of 51.21% from the company’s previous […] Time (ET) ... Target Price: Price: 2.01 Price Target: Upgrade: Price Target Upside (Daily) Upgrade: Comparables Edit. On average, they expect CloudMD Software & Services' share price to reach $3.50 in the next twelve months. this will be an acquisition target for major player very soon. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Latest ... 7:36a Expedia stock price target raised to $135 from $115 at Mizuho Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. In a report issued on December 17, Rob Goff from Echelon Wealth Partners assigned a Buy rating to CloudMD Software & Services (DOCRF – Research Report), with a price target of C$3.25. International stock quotes are delayed as per exchange requirements. I own shares of docrf. Export data to Excel for your own analysis. Robinhood raises $1B after trading halts to keep its platform running. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. View DOCRF historial stock data and compare to other stocks and exchanges. See what's happening in the market right now with MarketBeat's real-time news feed. Looking for new stock ideas? Cloudmd Software Services stock price prediction is an act of determining the future value of Cloudmd Software shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation.The successful prediction of Cloudmd Software stock future price could yield a significant profit. Their average twelve-month price target is $3.50, suggesting a possible upside of 112.1%.